KD Pharma Acquires Phytoextract and CBD Manufacturing Assets

CANNANNEW REPORT

Transaction advances KD Pharma’s cannabinoid manufacturing strategy BIOGGIO, Switzerland–(BUSINESS WIRE)–#APIs–The KD Pharma Group has acquired the manufacturing assets of a… Read More…..

Excerpt only …
READ MORE BELOW
Source : KD Pharma Acquires Phytoextract and CBD Manufacturing Assets

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.